Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Substitutes vs Secondary Intention Healing After Mohs Surgery
NCT07587749Phase 4Not yet recruiting
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Jan 2027
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 4, randomised trial (2 arms), sponsored by Baylor Scott & White Research Institute. Primary endpoint: Cosmetic Outcome Assessments at 12 weeks. Planned start Jan 2027; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07587749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07587749.